Mufaddal Mahesri

1.2k total citations
33 papers, 358 citations indexed

About

Mufaddal Mahesri is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Mufaddal Mahesri has authored 33 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 7 papers in Economics and Econometrics and 6 papers in General Health Professions. Recurrent topics in Mufaddal Mahesri's work include Chronic Disease Management Strategies (6 papers), Medication Adherence and Compliance (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Mufaddal Mahesri is often cited by papers focused on Chronic Disease Management Strategies (6 papers), Medication Adherence and Compliance (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Mufaddal Mahesri collaborates with scholars based in United States, Switzerland and Ireland. Mufaddal Mahesri's co-authors include Rishi Desai, Kristyn Chin, Seoyoung C. Kim, Sebastian Schneeweiß, Niteesh K. Choudhry, Raisa Levin, Julie C. Lauffenburger, Angela Tong, Jessica M. Franklin and Julie Barberio and has published in prestigious journals such as Blood, PLoS ONE and The American Journal of Medicine.

In The Last Decade

Mufaddal Mahesri

30 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mufaddal Mahesri United States 13 69 67 47 43 41 33 358
Vassilis Vargemezis Greece 17 66 1.0× 126 1.9× 28 0.6× 17 0.4× 64 1.6× 46 669
Michael P. Delaney United Kingdom 14 121 1.8× 83 1.2× 36 0.8× 14 0.3× 43 1.0× 24 686
Daniel Edmonston United States 11 133 1.9× 76 1.1× 15 0.3× 12 0.3× 29 0.7× 27 678
Cynthia de Luise United States 12 143 2.1× 179 2.7× 58 1.2× 16 0.4× 73 1.8× 17 516
Nicole Yurgin United States 15 78 1.1× 137 2.0× 108 2.3× 43 1.0× 79 1.9× 33 720
Sigrid Narum Norway 8 57 0.8× 90 1.3× 20 0.4× 7 0.2× 47 1.1× 19 370
Min Zhuo United States 16 100 1.4× 123 1.8× 14 0.3× 29 0.7× 53 1.3× 38 764
Kiang Liu United States 10 69 1.0× 141 2.1× 27 0.6× 18 0.4× 18 0.4× 12 535
Arianna Ghirardi Italy 8 149 2.2× 25 0.4× 16 0.3× 15 0.3× 33 0.8× 19 315
Breanne Lechner Canada 10 13 0.2× 127 1.9× 20 0.4× 21 0.5× 20 0.5× 19 409

Countries citing papers authored by Mufaddal Mahesri

Since Specialization
Citations

This map shows the geographic impact of Mufaddal Mahesri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mufaddal Mahesri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mufaddal Mahesri more than expected).

Fields of papers citing papers by Mufaddal Mahesri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mufaddal Mahesri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mufaddal Mahesri. The network helps show where Mufaddal Mahesri may publish in the future.

Co-authorship network of co-authors of Mufaddal Mahesri

This figure shows the co-authorship network connecting the top 25 collaborators of Mufaddal Mahesri. A scholar is included among the top collaborators of Mufaddal Mahesri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mufaddal Mahesri. Mufaddal Mahesri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desai, Rishi, Vijay R. Varma, Mufaddal Mahesri, et al.. (2025). Population‐Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study. Clinical Pharmacology & Therapeutics. 117(4). 1039–1050. 1 indexed citations
2.
Pritchard, Kevin, Mufaddal Mahesri, Chun-Ting Yang, et al.. (2024). Crosswalk Algorithms for Cognitive and Functional Outcomes Among 2013–2018 Medicare Beneficiaries With Dementia. Journal of the American Medical Directors Association. 25(10). 105168–105168. 1 indexed citations
3.
Feldman, William B., Mufaddal Mahesri, Ameet Sarpatwari, et al.. (2024). Removing the FDA’s Boxed Hepatotoxicity Warning and Liver Function Testing Requirement for Ambrisentan. JAMA Network Open. 7(7). e2419873–e2419873.
5.
Kim, Dae Hyun, Mufaddal Mahesri, Lily G. Bessette, et al.. (2023). Identifying Functional Status Impairment in People Living With Dementia Through Natural Language Processing of Clinical Documents: Cross-Sectional Study. Journal of Medical Internet Research. 26. e47739–e47739. 4 indexed citations
6.
Wang, Shirley, Dae Hyun Kim, Mufaddal Mahesri, et al.. (2023). Predicting Treatment Effects of a New‐to‐Market Drug in Clinical Practice Based on Phase III Randomized Trial Results. Clinical Pharmacology & Therapeutics. 114(4). 853–861. 2 indexed citations
7.
Mahesri, Mufaddal, et al.. (2021). External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure. PLoS ONE. 16(6). e0252903–e0252903. 12 indexed citations
8.
Fischer, Michael A., Mufaddal Mahesri, Joyce Lii, & Jeffrey A. Linder. (2021). Non-Visit-Based and Non-Infection-Related Antibiotic Use in the US: A Cohort Study of Privately Insured Patients During 2016–2018. Open Forum Infectious Diseases. 8(9). ofab412–ofab412. 5 indexed citations
9.
Mahesri, Mufaddal, Sebastian Schneeweiß, Denise Globe, et al.. (2020). Clinical outcomes following bone marrow transplantation in patients with sickle cell disease: A cohort study of US Medicaid enrollees. European Journal Of Haematology. 106(2). 273–280. 7 indexed citations
10.
Lauffenburger, Julie C., Mufaddal Mahesri, & Niteesh K. Choudhry. (2020). Not there yet: using data-driven methods to predict who becomes costly among low-cost patients with type 2 diabetes. BMC Endocrine Disorders. 20(1). 125–125. 5 indexed citations
11.
Desai, Rishi, Mufaddal Mahesri, Denise Globe, et al.. (2020). Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries. Annals of Hematology. 99(11). 2497–2505. 18 indexed citations
12.
Desai, Rishi, Vijay R. Varma, Tobias Gerhard, et al.. (2020). Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study. Alzheimer s & Dementia Translational Research & Clinical Interventions. 6(1). e12095–e12095. 21 indexed citations
13.
Desai, Rishi, Mufaddal Mahesri, Kristyn Chin, et al.. (2020). Epidemiologic Characterization of Heart Failure with Reduced or Preserved Ejection Fraction Populations Identified Using Medicare Claims. The American Journal of Medicine. 134(4). e241–e251. 24 indexed citations
14.
Desai, Rishi, Mufaddal Mahesri, Raisa Levin, et al.. (2019). Clinical Outcomes and Healthcare Utilization in Patients with Sickle Cell Disease: A Nationwide Cohort Study of Medicaid Beneficiaries. Blood. 134(Supplement_1). 3459–3459. 5 indexed citations
15.
Quintiliani, Lisa M., et al.. (2018). A Randomized Controlled Feasibility Trial in Behavioral Weight Management for Underserved Postpartum African American Women: The RENEW Study. Preventing Chronic Disease. 15. E77–E77. 10 indexed citations
16.
Franklin, Jessica M., Mufaddal Mahesri, Alexis A. Krumme, et al.. (2018). Time to Filling of New Prescriptions for Chronic Disease Medications Among a Cohort of Elderly Patients in the USA. Journal of General Internal Medicine. 33(11). 1877–1884. 7 indexed citations
17.
Desai, Rishi, Mufaddal Mahesri, Julie Barberio, et al.. (2018). Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures. JAMA Network Open. 1(3). e180826–e180826. 59 indexed citations
18.
Desai, Rishi, Mufaddal Mahesri, Joshua J. Gagne, et al.. (2018). Utilization Patterns of Oral Disease-Modifying Drugs in Commercially Insured Patients with Multiple Sclerosis. Journal of Managed Care & Specialty Pharmacy. 25(1). 113–121. 14 indexed citations
19.
Krumme, Alexis A., Gabriel Sanfélix‐Gimeno, Jessica M. Franklin, et al.. (2016). Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data. BMJ Open. 6(11). e011015–e011015. 5 indexed citations
20.
Abbas, Asad, et al.. (2013). Conservative Management of Spinal Tuberculosis: Initial Series from Pakistan. Asian Spine Journal. 7(2). 73–73. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026